Members of the University of Pittsburgh Cancer Institute (UPCI) Melanoma Program (MP) conduct studies to identify and provide insights into genes and proteins that play a pivotal role in melanoma inception and progression, and to develop and implement novel immunotherapies, molecularly targeted therapies, and combinations for patients with high-risk and advanced melanoma.
Read more about the Melanoma Program
Research Themes:
Identify and analyze key regulators of melanoma inception and progression to improve early detection and targeted interventions
Investigate melanoma immunobiology, develop better immunotherapies, and identify biomarkers to enhance personalized therapy
Conduct clinical trials which bring improved prevention, detection, and treatment methods to patients
